Regional Multi-Service Health System Signs New Six-Figure Agreement with CynergisTek for Cybersecurity Services
Midwest health system with multiple hospital locations turns to CynergisTek for comprehensive technical testing and risk assessment services
AUSTIN, Texas–(BUSINESS WIRE)–$CTEK #HealthcareITsecurity—CynergisTek (NYSE American: CTEK), a leading cybersecurity, privacy, compliance, and IT audit firm helping organizations in highly regulated industries navigate emerging security and privacy issues, adds a multi-hospital full service Midwest regional health system with more than 30 locations to the CynergisTek’s growing healthcare client base. In this six-figure agreement, CynergisTek will provide the health system with comprehensive cybersecurity services.
Under the agreement, CynergisTek’s Red Team will perform a series of tests to identify vulnerabilities and weaknesses within the health system’s information technology environment and a thorough assessment of the organization’s security program. The result and high-valued deliverable is a clearly defined remediation roadmap of priorities that the client can use to strategize for the upcoming year, gain budget approval, and shore up defenses to build resiliency against data breaches and cyber-attacks.
In a recent article on how to improve cyber resiliency, CynergisTek’s CEO and President, Mac McMillan is quoted saying, “Cybersecurity is a constant battle between good and bad. Good must work harder than bad, because bad only has to find one way to take advantage of you, and good has to find every way to stop them. But at the end of the day, you end up a lot better off down the road if you make good decisions based on continuous testing and evaluation of your program and controls.” Partnering with a third-party and expert in technical testing and security risk assessments is one of the first steps in making good decisions because it helps organizations understand their strengths and weaknesses.
“Adding yet another group of healthcare providers to our CynergisTek client community is a demonstration of our reputation and expertise in this space,” said Tim McMullen, COO at CynergisTek. The healthcare industry is one of the most sought-after targets for ransomware attacks. The threat landscape in healthcare is more expansive and hackers understand healthcare is more likely to pay a ransom because they can’t risk the disruption to operations and patient care delivery and in some cases leading to inadvertently harming a patient. McMullen goes on to say, “CynergisTek has dedicated years to this industry and will continue to support our clients in their journey to build resilience and strengthen their cybersecurity and privacy programs against future attacks.”
About CynergisTek, Inc.
CynergisTek (www.cynergistek.com), is a top-ranked cybersecurity consulting firm helping organizations in highly-regulated industries, including those in healthcare, government, and finance navigate emerging security and privacy issues. CynergisTek combines intelligence, expertise, and a distinct methodology to validate a company’s security posture and ensure the team is rehearsed, prepared, and resilient against threats. Since 2004, CynergisTek has been dedicated to hiring and retaining experts who bring real-life experience and hold advanced certifications to support and educate the industry by contributing to relevant industry associations. For more information, visit www.cynergistek.com or follow us on Twitter or Linkedin.
Cautionary Note Regarding Forward Looking Statements
This release contains certain forward-looking statements relating to the business of CynergisTek, Inc.. These forward-looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and can be identified by the use of forward-looking terminology such as “believes,” “expects,” “anticipates,” “would,” “could,” “intends,” “may,” “will,” or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including but not limited to uncertainties relating to product/services development; long and uncertain sales cycles; the ability to obtain or maintain proprietary intellectual property protection; future capital requirements; competition from other providers; the ability of the Company’s vendors to continue supplying the Company with supplies and services at comparable terms and prices; the Company’s ability to successfully compete and introduce enhancements and new features that achieve market acceptance and that keep pace with technological developments; the Company’s ability to maintain its brand and reputation and retain or replace its significant customers; cybersecurity risks and risks of damage and interruptions of information technology systems; the Company’s ability to retain key members of management and successfully integrate new executives; the Company’s ability to complete acquisitions, strategic investments, entry into new lines of business, divestitures, mergers or other transactions on acceptable terms, or at all; potential risks and uncertainties relating to the existing and ultimate impact of COVID-19, including the geographic spread, the severity of the virus, the duration of the COVID-19 outbreak, actions that may be taken by governmental authorities to contain the COVID-19 outbreak or to treat its impact, and the potential negative impacts of COVID-19 on the global economy and financial markets, and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in the Company’s Form 10-K and Form 10-Q filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Given the risks and uncertainties, readers should not place undue reliance on any forward-looking statement and should recognize that the statements are predictions of future results which may not occur as anticipated. Many of the risks listed above have been, and may further be, exacerbated by the COVID-19 pandemic, including its impact on the healthcare industry. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the risks and uncertainties described herein, as well as others not now anticipated. CynergisTek is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
Contacts
CynergisTek Investor Relations Contact:
CynergisTek, Inc.
Bryan Flynn
(512) 402-8550 x7
InvestorRelations@cynergistek.com
CynergisTek Media Contact:
Allison + Partners
Jaime Tero
415-755-8639
jaime.tero@allisonpr.com